Relmada Therapeutics, Inc. (RLMD)

Unlocking innovative treatments for the improvement of human health

News

View all news

News - Aug 7, 2025

Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC

News - Jul 31, 2025

Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

News - Jul 15, 2025

Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01

Events

View all events

Event - Aug 7, 2025 4:30 PM EDT

Q2 2025 Financial Results Conference Call

Read more

Event - May 23, 2025 9:30 AM EDT

2025 Annual Meeting of Stockholders

Read more

Event - May 12, 2025 4:30 PM EDT

Q1 2025 Financial Results Conference Call

Read more